Li, X.; Wang, X.; Liu, N.; Wang, Q.; Hu, J.
Inhibition of Metastatic Hepatocarcinoma by Combined Chemotherapy with Silencing VEGF/VEGFR2 Genes through a GalNAc-Modified Integrated Therapeutic System. Molecules 2022, 27, 2082.
https://doi.org/10.3390/molecules27072082
AMA Style
Li X, Wang X, Liu N, Wang Q, Hu J.
Inhibition of Metastatic Hepatocarcinoma by Combined Chemotherapy with Silencing VEGF/VEGFR2 Genes through a GalNAc-Modified Integrated Therapeutic System. Molecules. 2022; 27(7):2082.
https://doi.org/10.3390/molecules27072082
Chicago/Turabian Style
Li, Xunan, Xiang Wang, Nian Liu, Qiuyu Wang, and Jing Hu.
2022. "Inhibition of Metastatic Hepatocarcinoma by Combined Chemotherapy with Silencing VEGF/VEGFR2 Genes through a GalNAc-Modified Integrated Therapeutic System" Molecules 27, no. 7: 2082.
https://doi.org/10.3390/molecules27072082
APA Style
Li, X., Wang, X., Liu, N., Wang, Q., & Hu, J.
(2022). Inhibition of Metastatic Hepatocarcinoma by Combined Chemotherapy with Silencing VEGF/VEGFR2 Genes through a GalNAc-Modified Integrated Therapeutic System. Molecules, 27(7), 2082.
https://doi.org/10.3390/molecules27072082